Fingerprint
Dive into the research topics of 'The ODYSSEY DM-DYSLIPIDEMIA trial: Confirming the benefits of alirocumab in diabetic mixed dyslipidemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The ODYSSEY DM-DYSLIPIDEMIA trial: Confirming the benefits of alirocumab in diabetic mixed dyslipidemia
Paul Chan, Li Shao, Brian Tomlinson, Zhong Min Liu
Research output: Contribution to journal › Editorial › peer-review